Sclerosis: all 3,103 studies

Page 13 of 32. Open to participants first (314), then studies with results posted, then the rest; newest registration first within each.

• NF-κB Inhibition in Amyotrophic Lateral SclerosisStatus unknownNCT05031351Phase 2
• Assessment of Quality of Life and Psychological Problems in Patients With Multiple SclerosisCompletedNCT05029830
• Phase 1b Multiple Ascending Dose Study of Foralumab in Primary and Secondary Progressive MSWithdrawnNCT05029609Phase 1
• Hematopoietic Stem Cell Transplantation for Treatment of Multiple Sclerosis in SwedenCompletedNCT05029206
• Phase III Trial of AMX0035 for Amyotrophic Lateral Sclerosis TreatmentActive, not recruitingNCT05021536Phase 3
• Immune Response to Seasonal Influenza Vaccination in Multiple Sclerosis Patients Receiving CladribineStatus unknownNCT05019248
• The Role of Social and Territorial Inequalities in the Management and Prognosis of Multiple SclerosisStatus unknownNCT05017038
• Hydroxychloroquine and Indapamide in SPMSStatus unknownNCT05013463Phase 2
• The Reliability of the Nine Hole Peg Test in Patients With Multiple SclerosisActive, not recruitingNCT05012241
• A Study to Determine the Safety, Pharmacokinetics, and Pharmacodynamics of DNL343 in Participants With Amyotrophic Lateral SclerosisCompletedNCT05006352Phase 1
• Physiological Responses in Experimentally Induced Cognitive Fatigue in People With Multiple Sclerosis (MS)Status unknownNCT05003375
• Thalamic Nuclei Volumes in Multiple SclerosisStatus unknownNCT05002764
• Efficacy of Cognitive Behavioral Therapy on Fatigue, Cognition and Inflammatory Biomarkers in MS PatientsCompletedNCT05002062Not applicable
• Neurophysiological Assessment in Patients With Multiple SclerosisStatus unknownNCT04997343Not applicable
• Symptoms and Treatment Assessment of Ano-Rectal Disorders in Multiple Sclerosis Patients : STAR-QCompletedNCT04996186
• Sensitivity of Motor Assessment in MS - a Prospective Cohort StudyStatus unknownNCT04993274
• A Study of Lu AG06466 for the Treatment of Spasticity in Participants With Multiple SclerosisTerminatedNCT04990219Phase 1
• Territorial Implementation and Evaluation of a Multiple Sclerosis Expert Patient ProgramCompletedNCT04988880Not applicable
• Telerehabilitation in Multiple SclerosisStatus unknownNCT04979845Not applicable
• The Validity and Reliability of the Upper Extremity Exercise Testing (UULEX) in Patients With Multiple SclerosisStatus unknownNCT04979819Not applicable
• Using Patient-Reported Outcomes To Improve the Care of People With Multiple SclerosisCompletedNCT04979546Not applicable
• Functional Disorders of the Musculoskeletal System in People With Multiple SclerosisCompletedNCT04973501Not applicable
• Expanded Access Program for Tofersen in Participants With Superoxide Dismutase 1-Amyotropic Lateral SclerosisApproved for marketingNCT04972487
• Impact of Transcutaneous Auricular Vagus Nerve Stimulation on Digestive Symptoms in Systemic Sclerosis Systemic SclerosisCompletedNCT04971018Not applicable
• Ocrelizumab or Alemtuzumab Compared With Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis - a Phase-2 Randomised Controlled TrialTerminatedNCT04971005Phase 2
• Quantifying Gait Alteration in Multiple Sclerosis Using a Wearable DeviceCompletedNCT04969848
• The Effect of Emotional Freedom Technique on Depression, Anxiety and Distress of Individuals With Multiple SclerosisCompletedNCT04969562Not applicable
• Efficacy and Safety of Xacrel® (Ocrelizumab) in Participants With Relapsing Remitting Multiple SclerosisCompletedNCT04966338Phase 3
• Analysis of MS Patients Who Have Had Greater Than 60 Infusions of NatalizumabStatus unknownNCT04964700
• An Observational Study to Investigate the Role of B Cells in Multiple SclerosisStatus unknownNCT04964336
• Effects of a User-centered Exergame Training on Motor and Cognitive Functions in PwMSStatus unknownNCT04963335Not applicable
• Multimodal Brain Imaging StudyStatus unknownNCT04960540
• Application of Motor Unit Estimation Index in Amyotrophic Lateral Sclerosis and Related DiseasesStatus unknownNCT04956822
• Study on the Treatment With Water-filtered Infrared-A (wIRA) Radiation in Patients With Morphea and Sclerotic Graft-versus-host DiseaseTerminatedNCT04954573Not applicable
• Technology-assisted Conscientiousness Therapy for People With Multiple SclerosisCompletedNCT04953689Not applicable
• Appetite and Related Factors in Patients With ALSStatus unknownNCT04953624
• Pleiotropy and Mechanism of Peripheral Nerve Related Genes in the Progression of Amyotrophic Lateral SclerosisStatus unknownNCT04953494
• Home Care Needs and Current Nursing Status of Patients With Amyotrophic Lateral SclerosisStatus unknownNCT04953481
• Clinical Isolation Syndrome of Spinal Cord and Multiple SclerosisStatus unknownNCT04952246
• Sleep Disorders and the Onset and Progression of ALSStatus unknownNCT04952038
• Quantitative Analysis of Precise Brain Volume in Amyotrophic Lateral SclerosisCompletedNCT04952025
• The Treatment of Amyotrophic Lateral Sclerosis With Huollingshengji GranulesStatus unknownNCT04950933Phase 2/3
• Efficacy and Safety of Nitrazine in the Treatment of ALSStatus unknownNCT04950647Phase 2
• A Study of MK-2225 / ACE-1334 in Participants With Systemic Sclerosis With and Without Interstitial Lung Disease (MK-2225-002)TerminatedNCT04948554Phase 1
• Correlation Between Intestinal Microflora Metabolites and Amyotrophic Lateral SclerosisCompletedNCT04948346
• Regular Exercise Improves Physical Capacity and Promotes Neurotrophins in Patients With Multiple SclerosisCompletedNCT04944251Not applicable
• CONNECT Trial of eSupport Online Health-coach Moderated Support Groups for Multiple SclerosisCompletedNCT04943887Not applicable
• PET Study to Determine the Relationship Between Plasma Concentrations and Muscarinic Type 1 Receptor (M1AChR) Occupancy of PIPE-307 in Healthy VolunteersCompletedNCT04941781Phase 1
• The Effect of Self-Acupressure Application on Functional Composite and Quality of Life in Multiple Sclerosis PatientsCompletedNCT04936555Not applicable
• Investigation of Hand Functions and Related Parameters in People With Multiple SclerosisStatus unknownNCT04933110
• Tele-Assessment and Face-to-Face Evaluation of Functional Gait Assessment in Multiple SclerosisStatus unknownNCT04932616
• Description of Adherence to the Main Preventive Health Campaigns of Persons With Multiple SclerosisStatus unknownNCT04930380
• The Gut Microbiome in Adult Multiple SclerosisCompletedNCT04929145
• Multiple Sclerosis and Voiding Symptoms: How to Assess?CompletedNCT04928716
• Safety and Effectiveness of Cinnomer® (Glatiramer Acetate) in Multiple Sclerosis (MS) Treatment in IranCompletedNCT04928313
• Mycophenolate in Limited Cutaneous Systemic Sclerosis (MINIMISE-Pilot)Active, not recruitingNCT04927390Phase 2
• Observational Study in Patients With Relapsing-Remitting Multiple Sclerosis Switched to Bafiertam® From Dimethyl FumarateWithdrawnNCT04925778
• EEG and TMS-based Biomarkers of ALS, MS and FTDStatus unknownNCT04918251
• Exercise Booster Sessions in People With Multiple SclerosisCompletedNCT04913012Not applicable
• Evaluation of Safety, Tolerability and Preliminary Efficacy of EHP-101 in Relapsing Forms of Multiple SclerosisSuspendedNCT04909502Phase 2
• Creating Satisfying Engagement in Daily Life Through Coaching for People With Multiple SclerosisCompletedNCT04908085Not applicable
• Next-Gen MS: Feed-forward PRO Data for MS ResearchTerminatedNCT04907305
• The Possible Neuroprotective Effect of Ocrelizumab Via VEGF Protein Expression in Relapsing Multiple Sclerosis PatientsStatus unknownNCT04902690
• Swiss Study of the Impact of Mayzent on SPMS Patients in a Long-term Non-interventional StudyTerminatedNCT04895202
• Investigation of the Effects of Technology Supported Different Physiotherapy Approaches on Patients With Multiple SclerosisCompletedNCT04891341Not applicable
• Inspiratory Muscle Training With Powerbreath Device in Patients With ALSCompletedNCT04889248Not applicable
• Holter of Movement in Patients with Multiple Sclerosis in Controlled Environment.CompletedNCT04888689Not applicable
• The Effects of Respiratory-based Telerehabilitaion in Patients With MSStatus unknownNCT04887051Not applicable
• Holter of Movement in Patients with Multiple Sclerosis in Uncontrolled Environment.Active, not recruitingNCT04882891Not applicable
• Sport, Rehabilitation and Nutrition in Multiple Sclerosis: The LINUS ProjectStatus unknownNCT04881422Not applicable
• Tenofovir Alafenamide for Treatment of Symptoms and Neuroprotection in Relapsing Remitting Multiple SclerosisWithdrawnNCT04880577Phase 2
• Anti-Cholinergic Receptors Antibodies, Autonomic Profile and Dysautonomia Symptoms in PAF, ALS and POTS (DISAUT-AB)CompletedNCT04875949Not applicable
• EMDR for Depressed People With Multiple SclerosisStatus unknownNCT04875832Not applicable
• Investigation of the Effect of Ocrelizumab on Peripheral Lymphocyte Immunophenotypes with Suppressive Capacity in MSActive, not recruitingNCT04874597
• Validation of a Novel Instrument Task for Assessing Upper LimbCompletedNCT04868370
• COVID-19 and Multiple Sclerosis Disease Modifying TherapiesStatus unknownNCT04863586
• Validation of the French Adaptation of the MSWDQ-23 QuestionnaireCompletedNCT04860791
• Deficient T Regulatory Cell (Treg) Function in Patients With Relapsing Remitting Multiple SclerosisStatus unknownNCT04857489
• Effect of Variance on Error Correction During CouplingCompletedNCT04856384Not applicable
• Running Title: Walking to Music and in Silence on a TreadmillCompletedNCT04856345Not applicable
• Symptom Burden in Patients Treated With Ocrelizumab for Multiple SclerosisCompletedNCT04855617
• Clinical Trial on the Use of Cell Therapy in the Treatment of Patients With Amyotrophic Lateral SclerosisStatus unknownNCT04849065Phase 2
• A Multicenter Study to Assess Response to COVID-19 Vaccine in Multiple Sclerosis Participants Treated With OfatumumabCompletedNCT04847596
• Effects of Lutein Supplementation on Cognition and MPOD in Multiple Sclerosis Patients-Status unknownNCT04843813Not applicable
• Enoxacin for Amyotrophic Lateral Sclerosis (ALS)CompletedNCT04840823Phase 1/2
• TELEMS: Feasibility of Remote Patient Visits in MSCompletedNCT04838990Not applicable
• The Effect of Telerehabilitation Based Pilates Training in Multiple Sclerosis PatientsCompletedNCT04838886Not applicable
• Humoral and T-Cell Responses to COVID-19 Vaccination in Multiple Sclerosis Patients Treated With Ocrelizumab Treated With Ocrelizumab or NatalizumabCompletedNCT04837651
• Effect of Disease Modifying Therapy on Antibody Response to COVID19 Vaccination in Multiple SclerosisCompletedNCT04834401
• The Effects of Relaxation Techniques on Pain, Fatigue and Kinesiophobia in Multiple Sclerosis Patients: A Three Arms Randomized TrialCompletedNCT04833673Not applicable
• Study of Tysabri in Early Relapsing Remitting Multiple Sclerosis ParticipantsCompletedNCT04832399
• "Individual Patient Expanded Access IND to Treat Primary Lateral Sclerosis"No longer availableNCT04825613
• Effects of Repeated Mesenchymal Stem Cells (MSC) in Patients With Progressive Multiple SclerosisCompletedNCT04823000Phase 1/2
• Repeated Mesenchymal Stem Cell Injections in ALSCompletedNCT04821479Phase 1/2
• Botulinum Toxin a Vs Anticholinergic Treatment of Neurogenic Overactive Bladder in Patients with Multiple SclerosisTerminatedNCT04819360Phase 4
• The Use of Arabic Otago Exercise Program in People With Multiple SclerosisCompletedNCT04818008Not applicable
• Virtual Reality in Physical Therapy in Multiple SclerosisCompletedNCT04807738Not applicable
• Nature of the Link Between Executive Functions and Theory of Mind in Multiple SclerosisStatus unknownNCT04806217Not applicable
• Patient's TeleMonitoring With Amyotrophic Lateral Sclerosis Treated by Non Invasive Ventilation at Home.CompletedNCT04797845Not applicable
• Efficacy of COVID-19 Vaccination in Patients With Multiple Sclerosis Treated With Immune Modulating MedicationTerminatedNCT04796584

← Sclerosis overview